Latest implementation tools (8th April 2009)
Tools to aid implementation of recently published guidance.
Schizophrenia (update): Costing Tool and Slide Set
Medicines Adherence: Audit Support, Guide to Resources and Patient Information Resource
Prophylaxis against infective endocarditis: Question and Answer Document
Dementia: Audit Support
Needle and syringe programmes: Costing Tool
Personality disorders - borderline: Audit Support
Critical illness rehabilitation: Joint Position Statement and Slide Set
Sunitinib for the first-line treatment of advanced and/or metastati renal cell carcinoma: Costing Tool and Audit Support
Managing long term sickness and incapacity: Costing Tool, Slide Set, Checklist for Managing Absence and Guide to Resources
Promotion of physical activity in children: Audit Support for schools, Audit Support for local authorities, Slide Set for schools, Slide Set for local authorities and local strategic partnerships
Endoscopic radiofrequency ablation for gastro-oesophageal reflux disease: Audit Support
Deep dermal injection of non-absorbable gel polymer for HIV related facial lipoatrophy: Audit Support
Tools to aid implementation of recently published guidance.
Schizophrenia (update): Costing Tool and Slide Set
Medicines Adherence: Audit Support, Guide to Resources and Patient Information Resource
Prophylaxis against infective endocarditis: Question and Answer Document
Dementia: Audit Support
Needle and syringe programmes: Costing Tool
Personality disorders - borderline: Audit Support
Critical illness rehabilitation: Joint Position Statement and Slide Set
Sunitinib for the first-line treatment of advanced and/or metastati renal cell carcinoma: Costing Tool and Audit Support
Managing long term sickness and incapacity: Costing Tool, Slide Set, Checklist for Managing Absence and Guide to Resources
Promotion of physical activity in children: Audit Support for schools, Audit Support for local authorities, Slide Set for schools, Slide Set for local authorities and local strategic partnerships
Endoscopic radiofrequency ablation for gastro-oesophageal reflux disease: Audit Support
Deep dermal injection of non-absorbable gel polymer for HIV related facial lipoatrophy: Audit Support
Lung cancer (non-small-cell, first line treatment) - pemetrexed: appraisal consultation (15th April 2009)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a single technology appraisal (STA) of pemetrexed for the first-line treatment of non-small-cell lung cancer (NSCLC) and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of pemetrexed for the first-line treatment of advanced NSCLC. Closing date for comments is 6th May 2009.
Consultation
Spatial planning for health: draft scope consultation (16th April 2009)
NICE is developing public health programme guidance: Guidance for local authorities and primary care trusts on spatial planning. Closing date for comments is 15th May 2009.
Consultation
Promoting mental wellbeing at work: consultation on the draft guidance (20th April 2009)
Guidance for employers on promoting mental wellbeing through productive and healthy working conditions. Closing date for comments is 19th May 2009.
Consultation
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a single technology appraisal (STA) of pemetrexed for the first-line treatment of non-small-cell lung cancer (NSCLC) and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of pemetrexed for the first-line treatment of advanced NSCLC. Closing date for comments is 6th May 2009.
Consultation
Spatial planning for health: draft scope consultation (16th April 2009)
NICE is developing public health programme guidance: Guidance for local authorities and primary care trusts on spatial planning. Closing date for comments is 15th May 2009.
Consultation
Promoting mental wellbeing at work: consultation on the draft guidance (20th April 2009)
Guidance for employers on promoting mental wellbeing through productive and healthy working conditions. Closing date for comments is 19th May 2009.
Consultation
Combined bony and soft tissue reconstruction for hip joint stabilisation in proximal focal femoral deficiciency (PFFD Interventional procedure guidance IPG297 (22nd April 2009)
Children are sometimes born with defects of the hip joint and upper thigh bone, called proximal femoral focal deficiency, often abbreviated to PFFD. Surgical treatment, aiming to produce as functional a leg as possible, may be appropriate. This may also involve a corrective operation on the hip joint (sometimes referred to as the ‘superhip' procedure). The initial operation may be combined with other surgery to lengthen the leg and treat other problems such as poor knee function at the same time or at a later date.
Guidance
Endoscopic mastectomy and endoscopic wide local excision for breast cancer Interventional procedure guidance IPG296 (22nd April 2009)
Treatment for early breast cancer usually involves surgery to remove all or part of the breast. In this keyhole procedure, part or all of the breast tissue is removed using special instruments inserted through small skin incisions. The skin envelope of the breast and nipple are left intact, ready for an implant that can be inserted during the same operation.
Guidance
Ex-vivo hepatic resection and reimplantation for liver cancer Interventional procedure guidance IPG298 (22nd April 2009)
The liver may be affected by cancer, either spreading from other parts of the body or developing from within the organ. In some patients, the tumour may develop in parts of the liver that are dangerous or impossible to treat with surgery, for example, when the tumour is very close to major veins that connect to the liver. This procedure involves removing the liver from the body, cutting away the diseased tissue, and reimplanting the remaining tumour-free liver into the patient.
Guidance
Management of acute diarrhoea and vomiting due to gastroenteritis in children under 5 Clinical guideline CG84 (22nd April 2009)
This guideline applies to children younger than 5 years who present to a healthcare professional for advice in any setting. It covers diagnosis, assessment of dehydration, fluid management, nutritional management and the role of antibiotics and other therapies. It provides recommendations on the advice to be given to parents and carers, and also considers when care should be escalated - from home management through to hospital admission.
The guideline will assume that prescribers will use a drug's summary of product characteristics to inform their decisions for individual patients.
Guidance
Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension Clinical guideline CG85 (22nd April 2009)
The advice in the NICE guideline covers the diagnosis, treatment and care of:
Rivaroxaban for the prevention of venous thromboembolism Technology appraisal TA170 (22nd April 2009)
This guidance is about when rivaroxaban should be used to reduce the risk of thromboembolism in adults who have surgery to replace their hip or knee joints in the NHS in England and Wales. It explains guidance (advice) from NICE (the National Institute for Health and Clinical Excellence). It does not cover using rivaroxaban to reduce the risk of venous thromboembolism in adults who have had other types of surgery. It is written for people who are having or have had an operation to replace their hip or knee joints but it may also be useful for their families or carers or anyone with an interestin the topic.
Guidance
Children are sometimes born with defects of the hip joint and upper thigh bone, called proximal femoral focal deficiency, often abbreviated to PFFD. Surgical treatment, aiming to produce as functional a leg as possible, may be appropriate. This may also involve a corrective operation on the hip joint (sometimes referred to as the ‘superhip' procedure). The initial operation may be combined with other surgery to lengthen the leg and treat other problems such as poor knee function at the same time or at a later date.
Guidance
Endoscopic mastectomy and endoscopic wide local excision for breast cancer Interventional procedure guidance IPG296 (22nd April 2009)
Treatment for early breast cancer usually involves surgery to remove all or part of the breast. In this keyhole procedure, part or all of the breast tissue is removed using special instruments inserted through small skin incisions. The skin envelope of the breast and nipple are left intact, ready for an implant that can be inserted during the same operation.
Guidance
Ex-vivo hepatic resection and reimplantation for liver cancer Interventional procedure guidance IPG298 (22nd April 2009)
The liver may be affected by cancer, either spreading from other parts of the body or developing from within the organ. In some patients, the tumour may develop in parts of the liver that are dangerous or impossible to treat with surgery, for example, when the tumour is very close to major veins that connect to the liver. This procedure involves removing the liver from the body, cutting away the diseased tissue, and reimplanting the remaining tumour-free liver into the patient.
Guidance
Management of acute diarrhoea and vomiting due to gastroenteritis in children under 5 Clinical guideline CG84 (22nd April 2009)
This guideline applies to children younger than 5 years who present to a healthcare professional for advice in any setting. It covers diagnosis, assessment of dehydration, fluid management, nutritional management and the role of antibiotics and other therapies. It provides recommendations on the advice to be given to parents and carers, and also considers when care should be escalated - from home management through to hospital admission.
The guideline will assume that prescribers will use a drug's summary of product characteristics to inform their decisions for individual patients.
Guidance
Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension Clinical guideline CG85 (22nd April 2009)
The advice in the NICE guideline covers the diagnosis, treatment and care of:
- adults (18 years and over) with a diagnosis of the condition known as 'chronic open angle glaucoma'
- adults with a diagnosis of ocular hypertension (raised eye pressure)
- adults who are at a high risk of developing glaucoma.
- people under 18 years
- people with secondary glaucoma (glaucoma that is caused by other eye conditions, such as injury or inflammation)
- people with, or at risk of, types of glaucoma known as 'angle closure glaucoma (primary or secondary)' or acute glaucoma
- adults who have had glaucoma since birth or childhood.
Rivaroxaban for the prevention of venous thromboembolism Technology appraisal TA170 (22nd April 2009)
This guidance is about when rivaroxaban should be used to reduce the risk of thromboembolism in adults who have surgery to replace their hip or knee joints in the NHS in England and Wales. It explains guidance (advice) from NICE (the National Institute for Health and Clinical Excellence). It does not cover using rivaroxaban to reduce the risk of venous thromboembolism in adults who have had other types of surgery. It is written for people who are having or have had an operation to replace their hip or knee joints but it may also be useful for their families or carers or anyone with an interestin the topic.
Guidance
No comments:
Post a Comment